例如:"lncRNA", "apoptosis", "WRKY"

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.

J. Clin. Invest.2018 Feb 01;128(2):816-825. Epub 2018 Jan 16
Alix F Leblanc 1 , Jason A Sprowl 2 , Paola Alberti 3 , Alessia Chiorazzi 3 , W David Arnold 4 , Alice A Gibson 1 , Kristen W Hong 1 , Marissa S Pioso 1 , Mingqing Chen 1 , Kevin M Huang 1 , Vamsi Chodisetty 1 , Olivia Costa 2 , Tatiana Florea 2 , Peter de Bruijn 5 , Ron H Mathijssen 5 , Raquel E Reinbolt 6 , Maryam B Lustberg 6 , Lara E Sucheston-Campbell 7 , Guido Cavaletti 3 , Alex Sparreboom 1 , Shuiying Hu 1
Alix F Leblanc 1 , Jason A Sprowl 2 , Paola Alberti 3 , Alessia Chiorazzi 3 , W David Arnold 4 , Alice A Gibson 1 , Kristen W Hong 1 , Marissa S Pioso 1 , Mingqing Chen 1 , Kevin M Huang 1 , Vamsi Chodisetty 1 , Olivia Costa 2 , Tatiana Florea 2 , Peter de Bruijn 5 , Ron H Mathijssen 5 , Raquel E Reinbolt 6 , Maryam B Lustberg 6 , Lara E Sucheston-Campbell 7 , Guido Cavaletti 3 , Alex Sparreboom 1 , Shuiying Hu 1
+ et al

[No authors listed]

Author information
  • 1 Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  • 2 Department of Pharmaceutical, Social and Administrative Sciences, School of Pharmacy, D'Youville College, Buffalo, New York, USA.
  • 3 Experimental Neurology Unit and Milan Center for Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
  • 4 Division of Neuromuscular Disorders, Department of Neurology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
  • 5 Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • 6 Department of Internal Medicine, College of Medicine, and.
  • 7 Division of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.

摘要


Paclitaxel is among the most widely used anticancer drugs and is known to cause a dose-limiting peripheral neurotoxicity, the initiating mechanisms of which remain unknown. Here, we identified the murine solute carrier organic anion-transporting polypeptide B2 (OATP1B2) as a mediator of paclitaxel-induced neurotoxicity. Additionally, using established tests to assess acute and chronic paclitaxel-induced neurotoxicity, we found that genetic or pharmacologic knockout of OATP1B2 protected mice from mechanically induced allodynia, thermal hyperalgesia, and changes in digital maximal action potential amplitudes. The function of this transport system was inhibited by the tyrosine kinase inhibitor nilotinib through a noncompetitive mechanism, without compromising the anticancer properties of paclitaxel. Collectively, our findings reveal a pathway that explains the fundamental basis of paclitaxel-induced neurotoxicity, with potential implications for its therapeutic management.

KEYWORDS: Cancer, Oncology, Toxins/drugs/xenobiotics, Transport